| N=185 |  | |
---|---|---|---|
Characteristics | Males, n=60 | Females n=125 | P value |
Age (years) | 40.16667 (9.141) | 38.336 (8.065) | 0.1683 |
Weight (kg) | 61.51667 ( 10.058) | 57.92 (11.291) | 0.0372 |
Height (m) | 1.718644 (0.089) | 1.607258 (0 .084) | <0.001 |
Duration on EFV (months) | 6.941667 (9.967) | 10.30456 (12.272) | 0.0661 |
CNS Toxicity, | Â | Â | Â |
Yes | 26 [32.91] | 53 [67.09] | Â |
No | 34 [32.08] | 72 [67.92] | 0.904 |
Log EFV concentration | 1.382 (1.274) | 1.632 ( 1.069) | 0.1638 |
Genetic polymorphisms | Â | Â | Â |
CYP2B6*6 , | Â | Â | Â |
GG | 17 [29.82] | 40 [70.18] | Â |
GT | 29 [34.52] | 55 [65.48] | Â |
TT | 13 [33.33] | 26 [66.67] | 0.841 |
CYP2B6*18, | Â | Â | Â |
TT | 43 [32.58] | 89 [67.42] | Â |
TC | 14 [29.79] | 33 [70.21] | Â |
CC | 3 [50.00] | 3 [50.00] | 0.608 |
CYP2A6*9, | Â | Â | Â |
GG | 33 [30.00] | 77 [70.00] | Â |
TT | 8 [33.33] | 16 [66.67] | 0.748 |
CYP2A6*17, | Â | Â | Â |
GG | 38 [31.67] | 82 [68.33] | Â |
GA | 3 [20.00] | 12 [80.00] | Â |
AA | 1 [100] | 0 [0] | 0.212 |
ABCB1236 C/T | Â | Â | Â |
CC | 37 [32.17] | 78 [67.83] | Â |
CT | 5 [31.25] | 11 [68.75] | Â |
TT | 0 [0] | 6 [100] | 0.316 |